Fredun Pharmaceuticals Limited (BOM:539730)
India flag India · Delayed Price · Currency is INR
1,473.70
-19.75 (-1.32%)
At close: Nov 6, 2026

Fredun Pharmaceuticals Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
481.3326.21197.39156.23108.0763.35
Depreciation & Amortization
123.6981.8749.1437.4227.6521.33
Other Amortization
0.60.61.260.540.440.24
Other Operating Activities
621.84399.75303.08187.99155.4379
Change in Accounts Receivable
311.37844.36-1,123-302.89557.13-491.98
Change in Inventory
-831.84-299.16-648.91-248.74-1,037211.14
Change in Accounts Payable
-607.47-571.83818.4136.04107.26-113.44
Change in Income Taxes
-102.1424.2515.8112.45-27.91-5.45
Change in Other Net Operating Assets
161.99-687.03220.57116.57-35.53212
Operating Cash Flow
159.33119.02-165.98-4.39-144.09-23.8
Operating Cash Flow Growth
-55.77%-----

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-947.18-735.91-61.06-76.39-94.95-42.86
Sale of Property, Plant & Equipment
1.56-1.12-0.91.43
Investment in Securities
---3.6---
Investing Cash Flow
-945.62-735.91-63.54-76.39-94.05-41.43

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
-85.57640.82216.05271.781.97
Long-Term Debt Issued
-466.97--68.89129.29
Total Debt Issued
519.83552.54640.82216.05340.67131.25
Long-Term Debt Repaid
---24.45-26.42--
Total Debt Repaid
-2.89--24.45-26.42--
Net Debt Issued (Repaid)
516.95552.54616.37189.63340.67131.25
Issuance of Common Stock
217.517.510.33---
Other Financing Activities
478.01654.42-350.18-129.7-88.9-56.58
Financing Cash Flow
1,2121,214266.5159.93251.7774.67

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Miscellaneous Cash Flow Adjustments
-0---0-0-
Net Cash Flow
426.18597.5836.99-20.8513.639.44

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-787.85-616.89-227.04-80.78-239.03-66.66
Free Cash Flow Growth
------
Free Cash Flow Margin
-9.10%-9.71%-5.00%-2.32%-8.70%-2.97%
Free Cash Flow Per Share
-45.27-38.59-16.30-5.80-17.79-5.35
Levered Free Cash Flow
-1,190-1,066-551.85-269.38-445.24-337.49
Unlevered Free Cash Flow
-935.91-832.16-424.2-191.14-397.98-310.05

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
374.88374.88223.77136.592.8246.69
Change in Working Capital
-1,068-689.41-716.84-386.57-435.68-187.73